Pancreatic Cancer Treatment Market To Reach $8.3 Billion By 2033

Pancreatic Cancer Treatment Market Growth & Trends

The global pancreatic cancer treatment market size is expected to reach USD 8.3 billion by 2033, registering a CAGR of 12.4% from 2026 to 2033, according to a new report by Grand View Research, Inc. Increasing tobacco consumption, smoking, obesity, and growing awareness pertaining to various treatment options available are propelling the market growth at a global level. The peak incidence of pancreatic cancer is seen in the age group of 65 to 75 years. Thus, growing geriatric population is also expected to drive the growth during the forecast period.

According to an article published in the National Center for Biotechnology Information in 2015, pancreatic cancer is one of the most dangerous malignancies and is the fourth most common cause of cancer deaths in the U.S. Furthermore, pancreatic cancer is expected to be the second common cause of death in the U.S., by 2030. These factors together would propel the market growth in the forecast period.

 Request a free sample copy or view report summary: Pancreatic Cancer Treatment Market Report

Pancreatic Cancer Treatment Market Report Highlights

• The exocrine segment dominated the market with a share of 88.3% in 2025. Its dominance is supported by the high prevalence of pancreatic ductal adenocarcinoma, which accounts for most pancreatic cancer cases.

•  The chemotherapy segment dominated with a market share of 43.1% in 2025, supported by its central role in pancreatic cancer treatment. Its use across locally advanced and metastatic disease supports demand, while administration before or after surgery provides additional treatment options for eligible patients.

• The hospital pharmacies segment dominated with a market share of 45.7% in 2025, supported by the need for supervised cancer treatment and medicine dispensing within healthcare facilities.

• North America dominated the pancreatic cancer treatment market with a share of 39.2% in 2025, due to established oncology infrastructure and access to approved cancer medicines.

Pancreatic Cancer Treatment Market Segmentation

Grand View Research has segmented the pancreatic cancer treatment market on the basis of type, treatment, distribution channel, and region:

Pancreatic Cancer Treatment Type Outlook (Revenue, USD Billion, 2021 - 2033)

• Exocrine

• Endocrine

Pancreatic Cancer Treatment Treatment Outlook (Revenue, USD Billion, 2021 - 2033)

• Chemotherapy

• Radiation Therapy

• Others

Pancreatic Cancer Treatment Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)

• Hospital Pharmacies

• Retail Pharmacies

• Others

Pancreatic Cancer Treatment Regional Outlook (Revenue, USD Billion, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Pancreatic Cancer Treatment Market

• AstraZeneca

• Novartis AG

• Pfizer Inc.

• Ipsen Pharma

• Revolution Medicines, Inc.

• Exelixis, Inc.

• Merus N.V.

• Accuray Incorporated

• Siemens Healthineers AG (Varian Medical Systems)

• Elekta AB